{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:32:38Z","timestamp":1790886758931,"version":"4.1.0"},"reference-count":79,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-024-02135-y","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T04:23:45Z","timestamp":1730953425000},"page":"61-73","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Integrating the new pharmacological standard of care with traditional nutritional interventions in non-dialysis CKD"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8532-0182","authenticated-orcid":false,"given":"Luca","family":"De Nicola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adamasco","family":"Cupisti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"D\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Bellizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"issue":"7","key":"2135_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis A, Harhay MN, Ong ACM, Tummalapalli SL, Ortiz A, Fogo AB, Fliser D, Roy-Chaudhury P, Fontana M, Nangaku M, Wanner C, Malik C, Hradsky A, Adu D, Bavanandan S, Cusumano A, Sola L, Ulasi I, Jha V (2024) American society of nephrology; european renal association; international society of nephrology. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol 20(7):473\u2013485","journal-title":"Nat Rev Nephrol"},{"issue":"10159","key":"2135_CR2","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","volume":"392","author":"GBD 2017 Causes of Death Collaborators","year":"2018","unstructured":"GBD 2017 Causes of Death Collaborators (2018) Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet 392(10159):1736\u20131788","journal-title":"Lancet"},{"issue":"10","key":"2135_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41581-020-0315-4","volume":"16","author":"J Himmelfarb","year":"2020","unstructured":"Himmelfarb J, Vanholder R, Mehrotra R, Tonelli M (2020) The current and future landscape of dialysis. Nat Rev Nephrol 16(10):573\u2013585","journal-title":"Nat Rev Nephrol"},{"issue":"9981","key":"2135_CR4","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","volume":"385","author":"T Liyanage","year":"2015","unstructured":"Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, Rodgers A, Gallagher M, Kotwal S, Cass A, Perkovic V (2015) Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 385(9981):1975\u20131982","journal-title":"Lancet"},{"issue":"1","key":"2135_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.kint.2020.10.012","volume":"99","author":"MG Shlipak","year":"2021","unstructured":"Shlipak MG, Tummalapalli SL, Boulware LE, Grams ME, Ix JH, Jha V et al (2021) The case for early identification and intervention of chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int 99(1):34\u201347","journal-title":"Kidney Int"},{"issue":"8","key":"2135_CR6","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/ndt\/gfae027","volume":"39","author":"M Kanbay","year":"2024","unstructured":"Kanbay M, Copur S, Bakir CN, Covic A, Ortiz A, Tuttle KR (2024) Glomerular hyperfiltration as a therapeutic target for CKD. Nephrol Dial Transpl 39(8):1228\u20131238","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"2135_CR7","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1097\/01.ASN.0000068462.38661.89","volume":"14","author":"A Chagnac","year":"2003","unstructured":"Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y (2003) The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 14(6):1480\u20131486","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 2","key":"2135_CR8","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1017\/S0007114512002589","volume":"108","author":"MS Westerterp-Plantenga","year":"2012","unstructured":"Westerterp-Plantenga MS, Lemmens SG, Westerterp KR (2012) Dietary protein - its role in satiety, energetics, weight loss and health. Br J Nutr 108(Suppl 2):S105\u2013S112","journal-title":"Br J Nutr"},{"issue":"3","key":"2135_CR9","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00394-015-0923-0","volume":"55","author":"A Ogna","year":"2016","unstructured":"Ogna A, Forni Ogna V, Bochud M, Guessous I, Paccaud F, Burnier M, Wuerzner G (2016) Association between obesity and glomerular hyperfiltration: the confounding effect of smoking and sodium and protein intakes. Eur J Nutr 55(3):1089\u20131097","journal-title":"Eur J Nutr"},{"issue":"1","key":"2135_CR10","first-page":"98","volume":"35","author":"JH Jhee","year":"2020","unstructured":"Jhee JH, Kee YK, Park S, Kim H, Park JT, Han SH, Kang SW, Yoo TH (2020) High-protein diet with renal hyperfiltration is associated with rapid decline rate of renal function: a community-based prospective cohort study. Nephrol Dial Transpl 35(1):98\u2013106","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"2135_CR11","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/ki.2011.79","volume":"80","author":"FA Holtkamp","year":"2011","unstructured":"Holtkamp FA, de Zeeuw D, Thomas MC, Cooper ME, de Graeff PA, Hillege HJ, Parving HH, Brenner BM, Shahinfar S, Lambers Heerspink HJ (2011) An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function. Kidney Int 80(3):282\u2013287","journal-title":"Kidney Int"},{"issue":"4","key":"2135_CR12","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1053\/j.ajkd.2013.11.012","volume":"63","author":"AN Friedman","year":"2014","unstructured":"Friedman AN, Quinney SK, Inman M, Mattar SG, Shihabi Z, Moe S (2014) Influence of dietary protein on glomerular filtration before and after bariatric surgery: a cohort study. Am J Kidney Dis 63(4):598\u2013603","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"2135_CR13","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.3390\/jcm9072243","volume":"9","author":"L De Nicola","year":"2020","unstructured":"De Nicola L, Gabbai FB, Garofalo C, Conte G, Minutolo R (2020) Nephroprotection by SGLT2 inhibition: back to the future? J Clin Med 9(7):2243","journal-title":"J Clin Med"},{"issue":"6","key":"2135_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41581-020-0256-y","volume":"16","author":"V Vallon","year":"2020","unstructured":"Vallon V, Thomson SC (2020) The tubular hypothesis of nephron filtration and diabetic kidney disease. Nat Rev Nephrol 16(6):317\u2013336","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"2135_CR15","doi-asserted-by":"publisher","first-page":"F761","DOI":"10.1152\/ajprenal.00552.2020","volume":"320","author":"SC Thomson","year":"2021","unstructured":"Thomson SC, Vallon V (2021) Effects of SGLT2 inhibitor and dietary NaCl on glomerular hemodynamics assessed by micropuncture in diabetic rats. Am J Physiol Renal Physiol 320(5):F761\u2013F771","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"2135_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000506534","volume":"51","author":"M Packer","year":"2020","unstructured":"Packer M (2020) Mitigation of the adverse consequences of nutrient excess on the kidney: a unified hypothesis to explain the renoprotective effects of sodium-glucose cotransporter 2 inhibitors. Am J Nephrol 51(4):289\u2013293","journal-title":"Am J Nephrol"},{"key":"2135_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/apha.14011","volume":"8","author":"AT Layton","year":"2023","unstructured":"Layton AT, Vallon V (2023) Did you know how SGLT2 inhibitors protect the kidney? Acta Physiol (Oxf) 8:e14011","journal-title":"Acta Physiol (Oxf)"},{"issue":"2","key":"2135_CR18","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2337\/db23-0448","volume":"73","author":"E Ferrannini","year":"2024","unstructured":"Ferrannini E, Solini A, Baldi S, Scozzaro T, Polidori D, Natali A, Hansen MK (2024) Role of glycosuria in SGLT2 inhibitor-induced cardiorenal protection: a mechanistic analysis of the CREDENCE trial. Diabetes 73(2):250\u2013259","journal-title":"Diabetes"},{"issue":"7","key":"2135_CR19","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3390\/antiox13070768","volume":"13","author":"F Cort\u00e9s-Camacho","year":"2024","unstructured":"Cort\u00e9s-Camacho F, Zambrano-V\u00e1squez OR, Ar\u00e9chaga-Ocampo E, Casta\u00f1eda-S\u00e1nchez JI, Gonzaga-S\u00e1nchez JG, S\u00e1nchez-Gloria JL, S\u00e1nchez-Lozada LG, Osorio-Alonso H (2024) Sodium-glucose cotransporter inhibitors: cellular mechanisms involved in the lipid metabolism and the treatment of chronic kidney disease associated with metabolic syndrome. Antioxid (Basel) 13(7):768","journal-title":"Antioxid (Basel)"},{"issue":"12","key":"2135_CR20","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.3390\/nu13124349","volume":"13","author":"A Nakashima","year":"2021","unstructured":"Nakashima A, Kato K, Ohkido I, Yokoo T (2021) Role and treatment of insulin resistance in patients with chronic kidney disease: a review. Nutrients 13(12):4349","journal-title":"Nutrients"},{"issue":"10365","key":"2135_CR21","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/S0140-6736(22)02074-8","volume":"400","author":"Nuffield Department of Population Health Renal Studies Group; SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists\u2019 Consortium","year":"2022","unstructured":"Nuffield Department of Population Health Renal Studies Group; SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists\u2019 Consortium (2022) Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials. Lancet 400(10365):1788\u20131801","journal-title":"Lancet"},{"issue":"2","key":"2135_CR22","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/ndt\/gfad175","volume":"39","author":"F Caravaca-Font\u00e1n","year":"2024","unstructured":"Caravaca-Font\u00e1n F, Stevens K, Padr\u00f3n M et al (2024) Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritis. Nephrol Dial Transpl 39(2):328\u2013340","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"2135_CR23","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/dom.14986","volume":"25","author":"E Maddaloni","year":"2023","unstructured":"Maddaloni E, Cavallari I, La Porta Y, Appetecchia A, D\u2019Onofrio L, Grigioni F, Buzzetti R, Holman RR (2023) Impact of baseline kidney function on the effects of sodium-glucose co-transporter-2 inhibitors on kidney and heart failure outcomes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Obes Metab 25(5):1341\u20131350","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"2135_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S2213-8587(19)30384-5","volume":"8","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL, Karasik A, Thuresson M, Melzer-Cohen C, Chodick G, Khunti K, Wilding JPH, Garcia Rodriguez LA, Cea-Soriano L, Kohsaka S, Nicolucci A, Lucisano G, Lin FJ, Wang CY, Wittbrodt E, Fenici P, Kosiborod M (2020) Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study. Lancet Diabetes Endocrinol 8(1):27\u201335","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"2135_CR25","first-page":"1153","volume":"18","author":"C Melzer Cohen","year":"2023","unstructured":"Melzer Cohen C, Schechter M, Rozenberg A, Yanuv I, Sehtman-Shachar DR, Fishkin A, Rosenzweig D, Chodick G, Karasik A, Mosenzon O (2023) Long-term, real-world kidney outcomes with SGLT2i versus DPP4i in type 2 diabetes without cardiovascular or kidney disease. Clin J Am Soc Nephrol 18(9):1153\u20131162","journal-title":"Clin J Am Soc Nephrol"},{"issue":"21","key":"2135_CR26","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, DAPA-HF Trial Committees and Investigators et al (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381(21):1995\u20132008","journal-title":"N Engl J Med"},{"issue":"13","key":"2135_CR27","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/eurheartj\/ehab094","volume":"42","author":"HJL Heerspink","year":"2021","unstructured":"Heerspink HJL, Sj\u00f6str\u00f6m CD, Jongs N, Chertow GM, Kosiborod M, Hou FF, McMurray JJV, Rossing P, Correa-Rotter R, Kurlyandskaya R, Stefansson BV, Toto RD, Langkilde AM, Wheeler DC, DAPA-CKD Trial Committees and Investigators (2021) Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial. Eur Heart J 42(13):1216\u20131227","journal-title":"Eur Heart J"},{"issue":"22","key":"2135_CR28","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE, EMPA-REG OUTCOME Investigators (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373(22):2117\u20132128","journal-title":"N Engl J Med"},{"issue":"5S","key":"2135_CR29","first-page":"S1","volume":"102","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group","year":"2022","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group (2022) KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int 102(5S):S1\u2013S127","journal-title":"Kidney Int"},{"issue":"11","key":"2135_CR30","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1093\/ndt\/gfad112","volume":"38","author":"PB Mark","year":"2023","unstructured":"Mark PB, Sarafidis P, Ekart R, Ferro CJ, Balafa O, Fernandez-Fernandez B, Herrington WG, Rossignol P, Del Vecchio L, Valdivielso JM, Mallamaci F, Ortiz A, Nistor I, Cozzolino M (2023) SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA. Nephrol Dial Transpl 38(11):2444\u20132455","journal-title":"Nephrol Dial Transpl"},{"issue":"4S","key":"2135_CR31","first-page":"S117","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2024) KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 105(4S):S117\u2013S314","journal-title":"Kidney Int"},{"issue":"2","key":"2135_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","volume":"388","author":"WG Herrington","year":"2023","unstructured":"The EMPA-KIDNEY Collaborative Group, Herrington WG, Staplin N, Wanner C et al (2023) Empagliflozin in Patients with chronic kidney disease. N Engl J Med 388(2):117\u2013127","journal-title":"N Engl J Med"},{"issue":"2","key":"2135_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2403347","volume":"391","author":"V Perkovic","year":"2024","unstructured":"Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JFE, Bakris G, Baeres FMM, Idorn T, Bosch-Traberg H, Lausvig NL, Pratley R, FLOW Trial Committees and Investigators (2024) Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes. N Engl J Med 391(2):109\u2013121","journal-title":"N Engl J Med"},{"key":"2135_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03133-0","author":"JFE Mann","year":"2024","unstructured":"Mann JFE, Rossing P, Bakris G et al (2024) Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the flow trial. Nat Med. https:\/\/doi.org\/10.1038\/s41591-024-03133-0. (Epub ahead of print)","journal-title":"Nat Med"},{"issue":"8","key":"2135_CR35","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.clnu.2024.06.034","volume":"43","author":"O Anyiam","year":"2024","unstructured":"Anyiam O, Phillips B, Quinn K, Wilkinson D, Smith K, Atherton P, Idris I (2024) Metabolic effects of very-low calorie diet, semaglutide, or combination of the two, in individuals with type 2 diabetes mellitus. Clin Nutr 43(8):1907\u20131913","journal-title":"Clin Nutr"},{"key":"2135_CR36","doi-asserted-by":"publisher","first-page":"R276","DOI":"10.1152\/ajpregu.00280.2020","volume":"320","author":"G Jia","year":"2021","unstructured":"Jia G, Lockette W, Sowers JR (2021) Mineralocorticoid receptors in the pathogenesis of insulin resistance and related disorders: from basic studies to clinical disease. Am J Physiol Regul Integr Comp Physiol 320:R276\u2013R286","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"2135_CR37","doi-asserted-by":"publisher","first-page":"362","DOI":"10.2337\/dc23-1420","volume":"47","author":"T Ebert","year":"2024","unstructured":"Ebert T, Anker SD, Ruilope LM, Fioretto P, Fonseca V, Umpierrez GE, Birkenfeld AL, Lawatscheck R, Scott C, Rohwedder K, Rossing P, FIDELIO-DKD and FIGARO-DKD Investigators (2024) Outcomes with finerenone in patients with chronic kidney disease and type 2 diabetes by baseline insulin resistance. Diabetes Care 47(3):362\u2013370","journal-title":"Diabetes Care"},{"issue":"11","key":"2135_CR38","doi-asserted-by":"publisher","first-page":"1445981","DOI":"10.3389\/fnut.2024.1445981","volume":"24","author":"M Mensink","year":"2024","unstructured":"Mensink M (2024) Dietary protein, amino acids and type 2 diabetes mellitus: a short review. Front Nutr 24(11):1445981","journal-title":"Front Nutr"},{"key":"2135_CR39","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/ajcn\/nqab287","volume":"115","author":"CB Ebbeling","year":"2022","unstructured":"Ebbeling CB, Knapp A, Johnson A, Wong JMW, Greco KF, Ma C, Mora S, Ludwig DS (2022) Effects of a low-carbohydrate diet on insulin-resistant dyslipoproteinemia\u2014a randomized controlled feeding trial. Am J Clin Nutr 115:154\u2013162","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"2135_CR40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41387-020-00142-z","volume":"10","author":"X Yuan","year":"2020","unstructured":"Yuan X, Wang J, Yang S, Gao M, Cao L, Li X, Hong D, Tian S, Sun C (2020) Effect of the ketogenic diet on glycemic control, insulin resistance, and lipid metabolism in patients with T2DM: a systematic review and meta-analysis. Nutr Diabetes 10(1):38","journal-title":"Nutr Diabetes"},{"key":"2135_CR41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1146\/annurev.nutr.25.050304.092545","volume":"27","author":"F Tremblay","year":"2007","unstructured":"Tremblay F, Lavigne C, Jacques H, Marette A (2007) Role of dietary proteins and amino acids in the pathogenesis of insulin resistance. Annu Rev Nutr 27:293\u2013310","journal-title":"Annu Rev Nutr"},{"issue":"4","key":"2135_CR42","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1093\/ajcn\/85.4.1005","volume":"85","author":"HB Iglay","year":"2007","unstructured":"Iglay HB, Thyfault JP, Apolzan JW, Campbell WW (2007) Resistance training and dietary protein: effects on glucose tolerance and contents of skeletal muscle insulin signaling proteins in older persons. Am J Clin Nutr 85(4):1005\u20131013. https:\/\/doi.org\/10.1093\/ajcn\/85.4.1005","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"2135_CR43","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1172\/JCI86181","volume":"126","author":"L Koppe","year":"2016","unstructured":"Koppe L, Nyam E, Vivot K, Manning Fox JE, Dai XQ, Nguyen BN, Trudel D, Attan\u00e9 C, Moull\u00e9 VS, MacDonald PE, Ghislain J, Poitout V (2016) Urea impairs \u03b2 cell glycolysis and insulin secretion in chronic kidney disease. J Clin Invest 126(9):3598\u20133612","journal-title":"J Clin Invest"},{"issue":"4","key":"2135_CR44","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s40620-019-00617-y","volume":"32","author":"S Bianchi","year":"2019","unstructured":"Bianchi S, Aucella F, De Nicola L, Genovesi S, Paoletti E, Regolisti G (2019) Management of hyperkalemia in patients with kidney disease: a position paper endorsed by the Italian society of nephrology. J Nephrol 32(4):499\u2013516","journal-title":"J Nephrol"},{"issue":"2","key":"2135_CR45","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11739-023-03427-0","volume":"19","author":"L De Nicola","year":"2024","unstructured":"De Nicola L, Ferraro PM, Montagnani A, Pontremoli R, Dentali F, Sesti G (2024) Recommendations for the management of hyperkalemia in patients receiving renin-angiotensin-aldosterone system inhibitors. Intern Emerg Med 19(2):295\u2013306","journal-title":"Intern Emerg Med"},{"issue":"6","key":"2135_CR46","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1053\/j.jrn.2022.01.013","volume":"32","author":"JS Babich","year":"2022","unstructured":"Babich JS, Kalantar-Zadeh K, Joshi S (2022) Taking the kale out of hyperkalemia: plant foods and serum potassium in patients with kidney disease. J Renal Nutr 32(6):641\u2013649","journal-title":"J Renal Nutr"},{"issue":"3","key":"2135_CR47","doi-asserted-by":"publisher","first-page":"E261","DOI":"10.3390\/nu10030261","volume":"10","author":"A Cupisti","year":"2018","unstructured":"Cupisti A, Kovesdy CP, D\u2019Alessandro C, Kalantar-Zadeh K (2018) Dietary approach to recurrent or chronic hyperkalaemia in patients with decreased kidney function. Nutrients 10(3):E261. https:\/\/doi.org\/10.3390\/nu10030261","journal-title":"Nutrients"},{"key":"2135_CR48","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1056\/NEJMra1700312","volume":"377","author":"K Kalantar-Zadeh","year":"2017","unstructured":"Kalantar-Zadeh K, Fouque D (2017) Nutritional management of chronic kidney disease. N Engl J Med 377:1765\u20131776","journal-title":"N Engl J Med"},{"issue":"4","key":"2135_CR49","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.kint.2022.04.046","volume":"102","author":"L De Nicola","year":"2022","unstructured":"De Nicola L, Garofalo C, Borrelli S, Minutolo R (2022) Recommendations on nutritional intake of potassium in CKD: it\u2019s now time to be more flexible! Kidney Int 102(4):700\u2013703","journal-title":"Kidney Int"},{"issue":"9","key":"2135_CR50","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41581-020-0297-2","volume":"16","author":"JJ Carrero","year":"2020","unstructured":"Carrero JJ, Gonz\u00e1lez-Ortiz A, Avesani CM, Bakker SJL, Bellizzi V, Chauveau P, Clase CM, Cupisti A, Espinosa-Cuevas A, Molina P, Moreau K, Piccoli GB, Post A, Sezer S, Fouque D (2020) Plant-based diets to manage the risks and complications of chronic kidney disease. Nat Rev Nephrol 16(9):525\u2013542","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"2135_CR51","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/01.ASN.0000106014.20274.C7","volume":"15","author":"WE Mitch","year":"2004","unstructured":"Mitch WE, Remuzzi G (2004) Diets for patients with chronic kidney disease, still worth prescribing. J Am Soc Nephrol 15(1):234\u2013237","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2135_CR52","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/ki.1986.215","volume":"30","author":"TH Hostetter","year":"1986","unstructured":"Hostetter TH, Meyer TW, Rennke HG, Brenner BM (1986) Chronic effects of dietary protein in the rat with intact and reduced renal mass. Kidney Int 30(4):509\u2013517","journal-title":"Kidney Int"},{"issue":"1","key":"2135_CR53","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000350585","volume":"36","author":"V Bellizzi","year":"2013","unstructured":"Bellizzi V (2013) Low-protein diet or nutritional therapy in chronic kidney disease? Blood Purif 36(1):41\u201346","journal-title":"Blood Purif"},{"issue":"3 Suppl 1","key":"2135_CR54","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","volume":"76","author":"TA Ikizler","year":"2020","unstructured":"Ikizler TA, Burrowes JD, Byham-Gray LD et al (2020) KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am J Kidney Dis 76(3 Suppl 1):S1\u2013S107","journal-title":"Am J Kidney Dis"},{"key":"2135_CR55","first-page":"1","volume":"935","author":"Joint WHO\/FAO\/UNU Expert Consultation","year":"2007","unstructured":"Joint WHO\/FAO\/UNU Expert Consultation (2007) Protein and amino acid requirements in human nutrition. World Health Organ Tech Rep Ser 935:1\u2013265","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"10","key":"2135_CR56","doi-asserted-by":"publisher","first-page":"CD001892","DOI":"10.1002\/14651858.CD001892.pub5","volume":"10","author":"D Hahn","year":"2020","unstructured":"Hahn D, Hodson EM, Fouque D (2020) Low protein diets for non-diabetic adults with chronic kidney disease. Cochrane Database Syst Rev 10(10):CD001892. https:\/\/doi.org\/10.1002\/14651858.CD001892.pub5","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2135_CR57","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1093\/ajcn\/nqac156","volume":"116","author":"V Bellizzi","year":"2022","unstructured":"Bellizzi V, Signoriello S, Chiodini P, De Nicola L, ERIKA Study Group (2022) Reply to Mocanu CA et al. Am J Clin Nutr 116(3):838\u2013839","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"2135_CR58","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1093\/ajcn\/nqab417","volume":"115","author":"V Bellizzi","year":"2022","unstructured":"Bellizzi V, Signoriello S, Minutolo R, Di Iorio B, Nazzaro P, Garofalo C, Calella P, Chiodini P, De Nicola L, ERIKA Study Group Investigators of the Italian Society of Nephrology-Conservative Therapy of CKD Work Group (2022) No additional benefit of prescribing a very low-protein diet in patients with advanced chronic kidney disease under regular nephrology care: a pragmatic, randomized, controlled trial. Am J Clin Nutr 115(5):1404\u20131417","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"2135_CR59","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1681\/ASN.2015040369","volume":"27","author":"L Garneata","year":"2016","unstructured":"Garneata L, Stancu A, Dragomir D, Stefan G, Mircescu G (2016) Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. J Am Soc Nephrol 27(7):2164\u20132176","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2135_CR60","doi-asserted-by":"publisher","first-page":"682","DOI":"10.2215\/CJN.12391018","volume":"14","author":"H Kim","year":"2019","unstructured":"Kim H, Caulfield LE, Garcia-Larsen V, Steffen LM, Grams ME, Coresh J, Rebholz CM (2019) Plant-based diets and incident CKD and kidney function. Clin J Am Soc Nephrol 14(5):682\u2013691","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"2135_CR61","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1053\/j.ajkd.2023.05.007","volume":"82","author":"GY Heo","year":"2023","unstructured":"Heo GY, Koh HB, Kim HJ, Kim KW, Jung CY, Kim HW, Chang TI, Park JT, Yoo T-H, Kang S-W, Han SH (2023) Association of plant protein intake with risk of incident CKD: a UK biobank study. Am J Kidney Dis 82(6):687\u2013697","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"2135_CR62","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.clnu.2023.01.018","volume":"42","author":"GB Piccoli","year":"2023","unstructured":"Piccoli GB, Cederholm T, Avesani CM, Bakker SJL, Bellizzi V, Cuerda C, Cupisti A, Sabatino A, Schneider S, Torreggiani M, Fouque D, Carrero JJ, Barazzoni R (2023) Nutritional status and the risk of malnutrition in older adults with chronic kidney disease-implications for low protein intake and nutritional care: a critical review endorsed by ERN-ERA and ESPEN. Clin Nutr 42(4):443\u2013457","journal-title":"Clin Nutr"},{"issue":"5","key":"2135_CR63","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1053\/j.ajkd.2004.01.009","volume":"43","author":"L De Nicola","year":"2004","unstructured":"De Nicola L, Minutolo R, Bellizzi V, Zoccali C, Cianciaruso B, Andreucci VE, Fuiano G, Conte G, Investigators of the TArget Blood Pressure LEvels in Chronic Kidney Disease (TABLE in CKD) Study Group (2004) Achievement of target blood pressure levels in chronic kidney disease: a salty question? Am J Kidney Dis 43(5):782\u2013795","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"2135_CR64","first-page":"CD010070","volume":"6","author":"EJ McMahon","year":"2021","unstructured":"McMahon EJ, Campbell KL, Bauer JD, Mudge DW, Kelly JT (2021) Altered dietary salt intake for people with chronic kidney disease. Cochrane Database Syst Rev 6(6):CD010070","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"2135_CR65","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.ekir.2023.02.1078","volume":"8","author":"HJ Kim","year":"2023","unstructured":"Kim HJ, Jung CY, Kim HW, Park JT, Yoo TH, Kang SW, Park SK, Kim YH, Sung SA, Hyun YY, Oh KH, Han SH (2023) Proteinuria modifies the relationship between urinary sodium excretion and adverse kidney outcomes: findings from KNOW-CKD. Kidney Int Rep 8(5):1022\u20131033","journal-title":"Kidney Int Rep"},{"issue":"1","key":"2135_CR66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/ckj\/sfac198","volume":"16","author":"R Minutolo","year":"2022","unstructured":"Minutolo R, De Nicola L, Mallamaci F, Zoccali C (2022) Thiazide diuretics are back in CKD: the case of chlorthalidone. Clin Kidney J 16(1):41\u201351","journal-title":"Clin Kidney J"},{"issue":"3","key":"2135_CR67","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s11255-021-02944-1","volume":"54","author":"C Garofalo","year":"2022","unstructured":"Garofalo C, Borrelli S, De Stefano T, De Nicola L, Vita C, Peruzzu N, Netti A, Conte G, Provenzano M, Minutolo R (2022) 15-year-change of phenotype and prognosis in non-dialysis CKD patients referred to a nephrology clinic. Int Urol Nephrol 54(3):679\u2013686","journal-title":"Int Urol Nephrol"},{"issue":"11","key":"2135_CR68","doi-asserted-by":"publisher","first-page":"e488","DOI":"10.1097\/TP.0000000000004243","volume":"106","author":"LU Lavenburg","year":"2022","unstructured":"Lavenburg LU, Kim Y, Weinhandl ED, Johansen KL, Harhay MN (2022) Trends, social context, and transplant implications of obesity among incident dialysis patients in the United States. Transplantation 106(11):e488\u2013e498","journal-title":"Transplantation"},{"issue":"4","key":"2135_CR69","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1053\/j.ajkd.2023.09.014","volume":"83","author":"C Garofalo","year":"2024","unstructured":"Garofalo C, Borrelli S, Liberti ME, Chiodini P, Peccarino L, Pennino L, Polese L, De Gregorio I, Scognamiglio M, Ruotolo C, Provenzano M, Conte G, Minutolo R, De Nicola L (2024) Secular trend in GFR decline in non-dialysis CKD based on observational data from standard of care arms of trials. Am J Kidney Dis 83(4):435\u2013444","journal-title":"Am J Kidney Dis"},{"key":"2135_CR70","first-page":"411","volume":"87","author":"M Epstein","year":"1976","unstructured":"Epstein M, Hollenberg NK (1976) Age as a determinant of renal sodium conservation in normal man. J Lab Clin Med 87:411\u2013417","journal-title":"J Lab Clin Med"},{"issue":"12","key":"2135_CR71","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1093\/ndt\/gfaa252","volume":"36","author":"C Garofalo","year":"2021","unstructured":"Garofalo C, Provenzano M, Andreucci M, Pisani A, De Nicola L, Conte G, Borrelli S (2021) Predictive effect of salt intake on patient and kidney survival in non-dialysis CKD: competing risk analysis in older versus younger patients under nephrology care. Nephrol Dial Transpl 36(12):2232\u20132240","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"2135_CR72","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/HYPERTENSIONAHA.119.13077","volume":"74","author":"J Wei","year":"2019","unstructured":"Wei J, Zhang J, Jiang S, Wang L, Persson AEG, Liu R (2019) High-protein diet-induced glomerular hyperfiltration is dependent on neuronal nitric oxide synthase \u03b2 in the macula densa via tubuloglomerular feedback response. Hypertension 74(4):864\u2013871","journal-title":"Hypertension"},{"issue":"12","key":"2135_CR73","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1093\/ckj\/sfad176","volume":"16","author":"C Zoccali","year":"2023","unstructured":"Zoccali C, Bellizzi V, Minutolo R, Mallamaci F, Conte G, De Nicola L, on behalf of the Conservative Care of Renal Insufficiency of the Italian Society of Nephrology (2023) The effect of a ketogenic diet on weight loss in CKD: a randomized controlled trial in obese stage G1\u20133a CKD patients. Clin Kidney J 16(12):2309\u20132313","journal-title":"Clin Kidney J"},{"issue":"8","key":"2135_CR74","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1111\/dom.14411","volume":"23","author":"AB Van der Aart-van der Beek","year":"2021","unstructured":"Van der Aart-van der Beek AB, Cherney D, Laverman GD, Stefansson B, Van Raalte DH, Hoogenberg K, Reyner D, Li Q, Di Tanna GL, Greasley PJ, Heerspink HJL (2021) Renal haemodynamic response to sodium-glucose cotransporter-2 inhibition does not depend on protein intake: an analysis of three randomized controlled trials. Diabetes Obes Metab 23(8):1961\u20131967","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"2135_CR75","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1111\/dom.13731","volume":"21","author":"K Nunoi","year":"2019","unstructured":"Nunoi K, Sato Y, Kaku K, Yoshida A, Suganami H (2019) Renal effects of a sodium-glucose cotransporter 2 inhibitor, tofogliflozin, in relation to sodium intake and glycaemic status. Diabetes Obes Metab 21(7):1715\u20131724","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"2135_CR76","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/s41598-020-79687-z","volume":"11","author":"S Kinguchi","year":"2021","unstructured":"Kinguchi S, Wakui H, Ito Y, Kondo Y, Azushima K, Osada U, Yamakawa T, Iwamoto T, Yutoh J, Misumi T, Yasuda G, Yoshii T, Haruhara K, Kobayashi Y, Yamanaka T, Terauchi Y, Tamura K (2021) Relationship between basal sodium intake and the effects of dapagliflozin in albuminuric diabetic kidney disease. Sci Rep 11(1):951","journal-title":"Sci Rep"},{"key":"2135_CR77","first-page":"1462","volume":"8","author":"European Food Safety Authority; EFSA Panel on Dietetic Products, Nutrition, and Allergies","year":"2010","unstructured":"European Food Safety Authority; EFSA Panel on Dietetic Products, Nutrition, and Allergies (2010) Scientific opinion on dietary reference values for carbohydrates and dietary fibre. EFSA J 8:1462","journal-title":"EFSA J"},{"issue":"11","key":"2135_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260242","volume":"16","author":"S-M Kim","year":"2021","unstructured":"Kim S-M, Kim M-h, Ryu D-R, Oh HJ (2021) The dietary intake of chronic kidney disease according to stages: findings from the Korean national health and nutritional examination survey. PLoS ONE 16(11):e0260242","journal-title":"PLoS ONE"},{"key":"2135_CR79","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/ki.2012.420","volume":"83","author":"LW Moore","year":"2013","unstructured":"Moore LW, Byham-Gray LD, Parrott JS, Rigassio-Radler D, Mandayam S, Jones SL, Mitch WE, Gaber O (2013) The mean dietary protein intake at different stages of chronic kidney disease is higher than current guidelines. Kidney Int 83:724\u2013732","journal-title":"Kidney Int"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02135-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-024-02135-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02135-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:52:33Z","timestamp":1777564353000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/38\/1\/61\/8304166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["2135"],"URL":"https:\/\/doi.org\/10.1007\/s40620-024-02135-y","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"7 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Since this is a review article, ethical approval is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No experiment in human or animal was made.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Since this is a review article, no patients were involved.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent to participate"}}]}}